HANGZHOU, China, Oct. 13, 2025 /PRNewswire/ -- Jiuzi Holdings, Inc. (NASDAQ: JZXN, hereinafter referred to as the "Company") today elaborated…
GUANGZHOU, China, Oct. 13, 2025 /PRNewswire/ -- The 138th China Import and Export Fair (Canton Fair) is set to open…
Completed Enrollment in First-In-Human Phase I study of Less Invasive Approach Expected to Present 6-Month data in 2026 at a…
Investigational cell therapy bemdaneprocel continues to demonstrate a favorable safety profile at 36 months in Phase I trial participants Secondary…
KIGALI, Rwanda, Oct. 6, 2025 /PRNewswire/ -- Huawei and Rwanda's Ministry of Education announced the completion of the first phase of…
Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only therapy to significantly improve overall survival versus chemotherapy in this…
October 05, 2025 09:00 ET | Source: Spyre Therapeutics, Inc. WALTHAM, Mass., Oct. 05, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics,…
PARIS--(BUSINESS WIRE)--Regulatory News: In September 2025, the state-owned enterprise Navoiyuran (Uzbekistan), the Orano group (France), and the ITOCHU Corporation (Japan)…
NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer…
GENEVA, Sept. 24, 2025 /PRNewswire/ -- Just days after officially announcing her candidacy for the FIA Presidency, Swiss racing driver and entrepreneur…